Ho Jun Chin1, Shin Young Ahn2, Jiwon Ryu2, Sejoong Kim2, Ki Young Na3, Ki Woong Kim4, Dong-Wan Chae3, Cheol-Ho Kim3, Kwang-Il Kim3. 1. Department of Internal Medicine, Seoul National University Bundang Hopsital, Seongnam, Korea Department of Internal Mecidine, Seoul National University College of Medicine, Seoul, Korea Renal Institute, Clinical Research Center, Seoul National University College of Medicine, Seoul, Korea. 2. Department of Internal Medicine, Seoul National University Bundang Hopsital, Seongnam, Korea. 3. Department of Internal Medicine, Seoul National University Bundang Hopsital, Seongnam, Korea Department of Internal Mecidine, Seoul National University College of Medicine, Seoul, Korea. 4. Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea Department of Brain and Cognitive Science, Seoul National University College of Natural Sciences, Seoul, Korea.
Abstract
BACKGROUND: longitudinal relationship between renal function, disability and mortality has not been evaluated. OBJECTIVE: we investigated the temporal association between renal function and disability, and aimed to identify the influence of disability on mortality according to renal function in a cohort of older Koreans. DESIGN/ SETTING: Korean Longitudinal Study on Health and Aging is a prospective, population-based cohort. SUBJECTS: community-dwelling Koreans ≥65 years of age. MAIN OUTCOME MEASURES: Korean version of activities of daily living (ADL), Instrumental activities of daily living (IADL) and all-cause mortality. RESULTS: a total of 984 participants were followed for 5 years with a 70.9% participation rate. The participants were categorized into three groups according to their baseline estimated glomerular filtration rates (eGFRs) (Group I, ≥60; Group II, 45-59; and Group III, <45 ml/min/1.73 m(2)). Baseline eGFR was higher in participants who maintained functional status compared with participants who died or had disability at follow-up examination. The incidence of ADL/IADL decline was 13, 12.5 and 29.5% in participants who showed improvement, no change, and decline in renal function, respectively (P = 0.01). The hazard ratio for mortality in the subgroup with IADL disability was 1.87 (95% CI: 1.10-3.20, P = 0.022) in Group I, and 2.53 (95% CI: 1.57-4.09, P<0.001) in Groups II and III after adjustment. CONCLUSIONS: impaired renal function was related to disability and ADL/IADL decline. The effect of ADL/IADL disability on mortality was more prominent in participants with impaired eGFR.
BACKGROUND: longitudinal relationship between renal function, disability and mortality has not been evaluated. OBJECTIVE: we investigated the temporal association between renal function and disability, and aimed to identify the influence of disability on mortality according to renal function in a cohort of older Koreans. DESIGN/ SETTING: Korean Longitudinal Study on Health and Aging is a prospective, population-based cohort. SUBJECTS: community-dwelling Koreans ≥65 years of age. MAIN OUTCOME MEASURES: Korean version of activities of daily living (ADL), Instrumental activities of daily living (IADL) and all-cause mortality. RESULTS: a total of 984 participants were followed for 5 years with a 70.9% participation rate. The participants were categorized into three groups according to their baseline estimated glomerular filtration rates (eGFRs) (Group I, ≥60; Group II, 45-59; and Group III, <45 ml/min/1.73 m(2)). Baseline eGFR was higher in participants who maintained functional status compared with participants who died or had disability at follow-up examination. The incidence of ADL/IADL decline was 13, 12.5 and 29.5% in participants who showed improvement, no change, and decline in renal function, respectively (P = 0.01). The hazard ratio for mortality in the subgroup with IADL disability was 1.87 (95% CI: 1.10-3.20, P = 0.022) in Group I, and 2.53 (95% CI: 1.57-4.09, P<0.001) in Groups II and III after adjustment. CONCLUSIONS:impaired renal function was related to disability and ADL/IADL decline. The effect of ADL/IADL disability on mortality was more prominent in participants with impaired eGFR.
Authors: W Zhang; L Jia; D L X Liu; L Chen; Q Wang; K Song; S Nie; J Ma; X Chen; M Xiu; M Gao; D Zhao; Y Zheng; S Duan; Z Dong; Z Li; P Wang; B Fu; G Cai; X Sun; X Chen Journal: J Nutr Health Aging Date: 2019 Impact factor: 4.075
Authors: Heather J MacKinnon; Thomas J Wilkinson; Amy L Clarke; Douglas W Gould; Thomas F O'Sullivan; Soteris Xenophontos; Emma L Watson; Sally J Singh; Alice C Smith Journal: Ther Adv Chronic Dis Date: 2018-07-04 Impact factor: 5.091
Authors: C K Liu; J Milton; F-C Hsu; K M Beavers; V Yank; T Church; J D Shegog; S Kashaf; S Nayfield; A Newman; R S Stafford; B Nicklas; D E Weiner; R A Fielding Journal: J Clin Nephrol Ren Care Date: 2017-02-14
Authors: Edward Zimbudzi; Clement Lo; Sanjeeva Ranasinha; Peter G Kerr; Kevan R Polkinghorne; Helena Teede; Timothy Usherwood; Rowan G Walker; Greg Johnson; Greg Fulcher; Sophia Zoungas Journal: Health Expect Date: 2017-07-04 Impact factor: 3.377
Authors: Simon Ds Fraser; Jenny Barker; Paul J Roderick; Ho Ming Yuen; Adam Shardlow; James E Morris; Natasha J McIntyre; Richard J Fluck; Chris W McIntyre; Maarten W Taal Journal: BMJ Open Date: 2020-08-06 Impact factor: 2.692